The FDA and ECT

Affiliations

¹ From the *Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA; †Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC; Departments of ‡Psychiatry, §Pharmacological Sciences, and ‖Biomedical Informatics, Stony Brook University School of Medicine, Stony Brook, NY; and ¶Department of Psychiatry and Health Behavior, Medical College of Georgia at Augusta University, Augusta, GA.

Editorial

William M McDonald et al. J ECT. 2016 Jun.

. 2016 Jun;32(2):75-7.

doi: 10.1097/YCT.0000000000000326.

¹ From the *Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA; †Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, NC; Departments of ‡Psychiatry, §Pharmacological Sciences, and ‖Biomedical Informatics, Stony Brook University School of Medicine, Stony Brook, NY; and ¶Department of Psychiatry and Health Behavior, Medical College of Georgia at Augusta University, Augusta, GA.

No abstract available

References

1. Chanpattana W, Barton D, Kramer B, et al. ECT practice in Australia. J ECT. 2006;22:80.
1. Sienaert P, Falconieri T, Obbels J, et al. Improving practice in electroconvulsive therapy: a nationwide survey in Belgium. J ECT. 2016;32:29–32. - PubMed
1. Vera I, Sanz-Fuentenebro J, Urretavizcaya M, et al. Electroconvulsive therapy practice in Spain: a national survey. J ECT. 2016;32:55–61. - PubMed
1. Chanpattana W, Andrade C. ECT for treatment-resistant schizophrenia: a response from the Far East to the UK. NICE report. J ECT. 2006;22:4–12. - PubMed
1. Fink M. Challenges to British practice of electroconvulsive therapy. J ECT. 2006;22:30–32. - PubMed